In the nematode, C. elegans, the divergent GATA-type transcription factors MED-1 and MED-2 are encoded by an unlinked, redundant pair of intronless genes. The med-1,2 genes are among the first to be activated in the embryo and are critical for the specification of the 7-cell stage MS (mesoderm) and E (endoderm) precursor cells. We have previously shown that the binding site recognized by MED-1 is a noncanonical RAGTATAC site that is not expected from the resemblance of its single C4-type zinc finger to those of other known GATA factors, which recognize the consensus HGATAR. To date, no MED-like zinc fingers have been described outside of C. elegans. In order to understand the evolution of these transcription factors, and the evolution of gene networks that specify early cell fates in Caenorhabditis, we have identified med sequence homologs in the related nematodes C. briggsae and C. remanei. While C. briggsae encodes two med-like genes similar to C. elegans, we find evidence for seven distinct med-like genes in C. remanei. Somewhat unexpectedly, the coding regions of all med genes appear to lack introns. We report that the med homologs have similar expression in their respective species. We further show that the C. briggsae homologs, and at least five of the seven C. remanei homologs, can fully complement the embryonic lethal phenotype of a C. elegans med-1,2(À) strain. We conclude that Med function and expression have been conserved over tens of millions of years of evolution, and that there may be a mechanism that selects against the acquisition of introns in these genes. D
Introduction
Deployment of appropriate gene regulatory networks is the means by which different cells acquire different fates during metazoan development (Levine and Davidson, 2005) . Gene comparison among closely-related species is one method that can be used to learn more about such networks, as conserved features can reveal fundamental properties that change very little over evolutionary time (Yuh et al., 2002) . Such studies contribute to our understanding of how the generation of diversity among metazoans is related to changes in the interactions among genes.
We are interested in the evolution of the gene regulatory network that operates in mesendoderm specification in Caenorhabditis. At the 7-cell stage of embryonic development in C. elegans, the precursor cells MS and E are born (Sulston et al., 1983) . The E cell clonally establishes the entire intestine (midgut), which consists of 20 cells at hatching, while its sister cell, MS, generates 80 cells that are primarily mesodermal in character, including body wall muscle and cells of the posterior half of the feeding organ, the pharynx.
The transcriptional regulatory cascade that controls specification of MS and E in C. elegans is well understood (Fig. 1 ) . The maternal gene skn-1 encodes a bZIP/homeodomain transcription factor required to specify MS and E: loss of skn-1 function results in a transformation of both MS and E into the mesectodermal precursor C, which makes body wall muscle and hypodermis (Bowerman et al., 1992) . In the mother of MS and E, called EMS, SKN-1 activates the expression of the med-1 and med-2 genes (Bowerman et al., 1993; Maduro et al., 2001) . Depletion of med-1,2 by RNAi also results in a transformation of MS and E to C, although E is correctly specified in approximately half of mutant embryos (Maduro et al., 2001) . In the E cell, MED-1,2 activate the genes end-1 and end-3, which encode a pair of GATA factors that specify an endoderm fate Maduro et al., 2005a) . In the MS cell, the corepressor POP-1 blocks the ability of MED-1,2 to activate end-1,3, allowing the meds to promote a mesodermal fate . The repressive function of POP-1 is blocked in the E cell by transduction of a Wnt/MAPK/Src signal that originates from a cell -cell interaction between EMS and its sister cell, P 2 (Bei et al., 2002; Goldstein, 1992; Rocheleau et al., 1997 Rocheleau et al., , 1999 Shin et al., 1999; Thorpe et al., 1997) . POP-1 then functions as an activator, and along with the Caudal-like protein PAL-1, also contributes to E specification in parallel with med-1,2 (Maduro et al., 2005b) . The med-1 and med-2 genes therefore play a critical role in the specification of the MS and E progenitors, as they function at the interface of SKN-1 activation and transduction of a signal initiated by the P 2 -EMS interaction.
The med-1 and med-2 genes encode nearly-identical single C4 zinc finger proteins with similarity to the GATA family of transcription factors, which recognize the canonical binding site HGATAR (Lowry and Atchley, 2000; Maduro et al., 2001) . MED-1 (and presumably MED-2, whose DNA-binding domain differs by only a single amino acid) recognizes RAGTATAC sites, suggesting that MED-1,2 have diverged in function from the GATA family (Broitman-Maduro et al., 2005) . No proteins similar to MED-1 are known to exist outside of Caenorhabditis that are not themselves more similar to canonical GATA factors, suggesting that they may be a nematode invention.
Because of the uniqueness of the MEDs among eukaryotic regulators, little is known of their evolutionary origin, and structure -function properties of the MED DNA-binding domain have yet to be elucidated.
In order to expand the collection of known MED-like regulators, and as first step toward studying the mesendoderm gene network in other species, we have mined the genome sequences of the related nematodes, C. briggsae (a hermaphroditic species) and C. remanei (a male-female species). C. remanei and C. briggsae are more closely related to each other than C. elegans is from either (Cho et al., 2004; Kiontke et al., 2004) . By some estimates, C. elegans is 80-110 million years diverged from the last common ancestor to C. briggsae, and hence C. remanei (Coghlan and Wolfe, 2002; Stein et al., 2003) . In this study, we compare the structure and genome organization of the med homologs from C. briggsae (two med genes) and C. remanei (seven med genes), and provide evidence that their expression and function have been conserved.
Materials and methods

Strains and genetics
The following strains were used in this work: PB4641 (wild-type C. remanei strain), AF16 (wild-type C. briggsae), N2 (wild-type C. elegans), MS240 , pMM808]], MS247 [med-1(ok804) X; med-2(cx9744) III; irDp1(III;f)]. Transgenic strains used to test rescue are listed in Table 1 . The free duplication irDp1 (carried by MS247) was derived from the free duplication sDp3, which carries a single copy of med-2, after spontaneous integration of an array (irEx14) consisting of the Ce-med-1 plasmid pMM277, the unc-32-rescuing plasmid pAIE5 (Pujol et al., 2001) , and an unc-119::YFP reporter plasmid (pMM531). A more detailed description of the properties of MS247 will appear elsewhere. Fig. 1 . Simplified representation of the regulatory cascade specifying MS and E in C. elegans. Diagrams of a 4-cell and 8-cell embryo are shown for reference. The maternal SKN-1 transcription factor activates zygotic expression of med-1 and med-2 in EMS (Maduro et al., 2001) . In turn, MED-1,2 activate target genes in MS and E to specify their fates. In the E cell, MED-1,2 activate end-1,3 to specify an endodermal fate . The Wnt effector POP-1 is a coregulator along with the MEDs: in MS, POP-1 represses end-1,3, while in the E cell, the repressive activity of POP-1 is blocked as a result of the Wnt signaling event that polarizes EMS at the 4-cell stage (Goldstein, 1992; Rocheleau et al., 1997; Thorpe et al., 1997) . In E, POP-1 and PAL-1 also function as end-1,3 activators in parallel with the MEDs Maduro et al., 2005b) . MS gives rise to primarily mesodermal cell types, including body wall muscle and the posterior half of the pharynx. The E cell clonally establishes the entire midgut (intestine). Sister cells are joined by a short line, and the nuclei of EMS, MS, and E are shaded black. In this and other figures, embryos are shown with anterior to the left and dorsal up. [med-1(ok804) ; med-2(cx9744); irDp1] animals were made transgenic for a plasmid or PCR product containing the indicated gene and an unc-119::CFP reporter. Lines that could be propagated in the absence of the irDp1 balancer were considered to be rescued. For those that did not rescue, lines were constructed that also contained the rol-6 D marker plasmid (pRF4) to facilitate maintenance of the transgenes. Only animals expressing unc-119::CFP (indicative of the test array) but not unc-119::YFP (indicative of irDp1) were scored. For those genes that rescued, only unc-119::CFP embryos were scored.
b Non-irDp1 MS247 segregants (i.e., embryos lacking unc-119::YFP) were scored. n/a, not applicable.
Identification of C. briggsae and C. remanei med genes
The C. briggsae med homologs correspond to CBG18154 (Cb-med-1) and CBG18155 (Cb-med-2) in WormBase (http://www.wormbase.org, release WS140). To identify candidate med genes from C. remanei, we used a TBLASTN search of the preliminary genome assembly of C. remanei (as of 7/ 29/2004) with Ce-MED-1 using the Washington University BLAST server (http://www.genome.wustl.edu/blast/client.pl). Sequences were extended in the 5V and 3V directions by correlating the aligned segment pairs to the sequence files downloaded from the Washington University server (ftp://www.genome. wustl.edu/pub/seqmgr/remanei/plasmid _ assembly/). Gene sequences were compiled, annotated, and analyzed using Vector NTI 6 (Informax) on a Dell PC. The Accession numbers for the Cr-med genes are as follows: Cr-med-1, -2, and -3, DQ288162; Cr-med-4 and -5, DQ288163; Cr-med-6, DQ288164; and Cr-med-7, DQ288165.
RNA interference (RNAi)
For RNAi experiments, double-stranded RNA (dsRNA) was synthesized using the T7 MEGAscript kit (Ambion) from a PCR product containing the Crmed-1, Cr-med-3, or GFP coding regions tagged with the T7 RNA polymerase recognition sequence on both ends. dsRNA at 4 Ag/AL was injected into both gonad arms of C. remanei females as was described for C. elegans hermaphrodites (Fire et al., 1998) . Depletion of skn-1 for testing the Cr-med-1::GFP translational fusion strain MS240 was performed by placing L2 animals on E. coli HT115 bacteria induced to accumulate skn-1 dsRNA (Montgomery, 2004) , and scoring progeny embryos in the uterus of these animals 3 days later. All RNAi experiments were performed at 20-C.
Transgenic C. elegans strains and plasmid construction
Transgenic animals were generated as described (Mello et al., 1991) . The Crmed-1::GFP::MED-1 fusion pMM808 was constructed as follows. The Cr-med-1 promoter and coding region/3VUTR were sequentially cloned into a pBluescript KS(-) backbone as separate PCR products amplified from PB4641 genomic
DNA. An open-ended GFP cassette, amplified from vector pPD95.67 (a gift from Andrew Fire, Stanford University), was inserted at the join between these segments. PCR and cloning were performed according to standard protocols; oligonucleotide sequences and cloning details are available upon request.
For rescue assays, plasmids carrying Ce-med-1 (pMM277), Ce-med-2 (pMM493), Cb-med-1 (pMM556), and Cr-med-1 (pMM807), and PCR products carrying the remaining Cr-med genes were generated containing¨0.5 kbp -1 kbp 5V to the coding region and¨0.3 kbp 3V sequence. Plasmid DNA (50 -100 ng/AL) or gel-purified PCR products (20 ng/AL) were coinjected with unc-119::CFP (pMM809) into MS247. Lines that carried unc-119::CFP but lacked unc-119::YFP (indicative of irDp1) were identified using appropriate filter sets (Miller et al., 1999 ) on a Leica dissecting microscope. The absence of irDp1 could also be confirmed because these strains lacked an adult egg-laying defect associated with irDp1. Thereafter, rescued lines were self-maintaining, and transgenic embryos could be scored by pan-neuronal unc-119::CFP expression from midembryogenesis to adulthood (Maduro and Pilgrim, 1995) . For Cr-med-2 and Cr-med-7, which did not rescue, lines were made in which the arrays were also marked with rol-6 D (Mello et al., 1991) . PCR confirmed the presence of Crmed-2 and Cr-med-7 in these strains.
In situ hybridization
Detection of med transcripts in whole-mount embryo preparations was performed essentially as described (Seydoux and Fire, 1995) , except that embryos were fixed using Streck Tissue Fixative (STF; Streck Laboratories, Inc.) and antisense RNA probes were used. A more detailed protocol will appear elsewhere.
RT-PCR analysis
Embryos were obtained from C. remanei females by bleaching. After homogenization in Trizol (Invitrogen), total RNA was purified from the aqueous phase using the Qiagen RNeasy Kit according to the manufacturer's instructions. Residual genomic DNA was removed by treatment with DNaseI (Ambion). First-strand and PCR primers were designed to target specific Crmed genes. Superscript II Reverse Transcriptase (Invitrogen) was used according to the manufacturer's instructions, except that 0.5 AL of T4gp32 (USB) was added to the RT reactions in 10 AL total volume.
Results
C. elegans and C. briggsae have two med genes, while C. remanei has seven
In C. elegans, the med-1 and med-2 genes are found on separate chromosomes (Fig. 2) (Maduro et al., 2001 ). In C. briggsae, there are two med-like genes found within 2 kbp of each other in an inverted orientation. In both C. elegans and C. briggsae, the intraspecific MED paralogs are nearly identical (98% for Ce-MED-1/2 and 97% for Cb-MED-1/2), while Ce-MED-1 and Cb-MED-1 are only 29% identical overall, consistent with recent duplication. We used the sequence of C. elegans MED-1 to search contigs from the preliminary genome assembly of C. remanei. Using the TBLASTN algorithm (Altschul et al., 1990) , seven distinct coding regions were identified (Figs. 2 and 3). Like their C. elegans and C. briggsae counterparts, all seven Cr-med genes appear to lack introns, as we could find no good candidate splice donor and acceptor sites similar to those used in C. elegans (Blumenthal and Steward, 1997) . The conservation of amino acids and lack of in-frame stop codons across the coding regions further support an intronless structure (Fig. 3) . Putative polyadenylation sites (AATAAA) occur within 73 -108 base pairs downstream of predicted Cb-meds and Cr-meds (Fig. 2) . The C. remanei med genes display a combination of linked and unlinked duplications: Cr-med-1, -2, and -3 are located within 5 kbp of each other, while Cr-med-4 and -5 appear in adjacent, parallel orientation within 2 kbp (Fig. 2) . The remaining genes, Cr-med-6 and Cr-med-7, appear on separate contigs. As these identifications were based on a preliminary sequence assembly, further synteny among all the Cr-med genes, and the existence of additional med paralogs, cannot be ruled out.
Most of the Cr-med genes encode proteins of a similar size (164 -197aa), while Cr-med-2 contains a 5V truncated coding region and is predicted to encode a 93-aa polypeptide that includes the DNA-binding domain (Figs. 2 and 3 ). An inspection of the protein alignments ( Fig. 3 ) and a phylogenetic tree generated from their DNA-binding domains ( Fig. 4C ) strongly suggest that the intraspecific med duplications arose from a single ancestral gene by duplication. Hence, the formation and retention of new med paralogs in Caenorhabditis appear to be a common occurrence for this gene family.
Conserved structural features of the MED class of GATA factors
The Ce-MED proteins contain a single C4-type zinc finger and basic domain which recognize a non-GATA consensus sequence (Broitman- Maduro et al., 2005) . By alignment with GATA DNA-binding domains whose solution structures have been determined, MED-1,2 contain apparent amino acid differences at positions known to make base-specific contacts (Broitman-Maduro et al., 2005; Omichinski et al., 1993; Starich et al., 1998) . We examined the entire suite of 11 MED-like coding regions to identify amino acids that may define this divergent GATA subtype. An alignment of the predicted DNAbinding domains of the C. elegans and C. remanei MEDs, as well as those of other GATA factors, reveals structural similarities (Fig. 4A) . First, the MED zinc fingers all include an extra amino acid between the cysteine pairs: The fungal AreA, chicken cGATA-1, and C. elegans ELT-1 and ELT-3 GATA factors contain 17 residues between the 2nd and 3rd cysteines, while all of the MED proteins contain 18, raising the intriguing possibility that the additional amino acid accounts for the GTATA core of the MED binding site. Second, we can identify nine amino acids that occur among all MED proteins, but which do not occur in other GATA factors (indicated by asterisks in Fig.  4A ). Although the functional significance of these amino acids is not yet known, their high degree of conservation suggests that at least some of them may mediate protein -DNA interactions that determine MED binding specificity. Finally, a phylogenetic tree generated from the alignment shown in Fig. 4A validates the notion that the MEDs do indeed form a distinct subgroup of GATA factors (Fig. 4B ).
5V flanking gene sequences predict similar expression of Cr-med genes
In addition to similar coding regions as their C. elegans counterparts, the Cb-med and Cr-med genes display multiple recognition sequences for the SKN-1 transcription factor in the 5V flanking sequence (Fig. 2) . SKN-1 has structural features found in both bZIP and homeodomain transcription factors, and its core binding site has been determined as RTCAT (Blackwell et al., 1994) . Of the known direct SKN-1 targets in C. elegans, regulation by SKN-1 in vivo appears to require clusters of SKN-1 sites in close proximity (An and Blackwell, 2003; Maduro et al., 2001 ). Both C. elegans med genes contain clusters of SKN-1 sites¨90 bp upstream of the start codon. These sites mediate binding by SKN-1 in vitro and are required for activation of a med-1 reporter gene in vivo (Maduro et al., 2001 ). For both Cbmed genes, and five of the seven Cr-med genes, there are at least six SKN-1 sites within the 250 bp directly upstream of the predicted start codon. As this is expected to occur by chance in less than 0.5% of all DNA segments of similar size and base composition, the presence of these sites suggests that they have undergone positive selection. The occurrence of multiple SKN-1 sites in the Cb-med and Cr-med genes, therefore, suggests that most of them are direct targets of a SKN-1-like activator. Two of the Cr-med homologs have anomalies that suggest that they may not be expressed at high efficiency downstream of SKN-1. While all other med genes except Cr-med-2 and Cr-med-7 contain overlapping SKN-1 sites of the form RTCATCAT (one site underlined, the other overlapping site in italics), Cr-med-2 contains only a single SKN-1 site in its upstream region, and while Cr-med-7 contains four SKN-1 sites in close proximity, none of these is present in an overlapping fashion. Hence, there is reason to suspect that Cr-med-2 and Cr-med-7 may not efficiently recruit SKN-1 (discussed below).
Conservation of Cr-med expression
Embryonic development of C. remanei has not been characterized in detail, but is superficially similar to that of C. elegans (Fig. 5) . We therefore sought to determine if the molecular basis for mesendoderm specification was also conserved. Previous evidence suggested that Ce-med-1,2 are transcribed at the 4-cell stage (Maduro et al., 2001 ). We confirmed Ce-med-1,2 expression by in situ hybridization using an antisense Ce-med-1 probe, which should detect both med genes due to their high degree of nucleotide similarity (Maduro et al., 2001) . As expected, we detected nascent Ce-med mRNA transcripts in the EMS nucleus (Fig. 6A) . To determine whether the Cr-med genes are similarly transcribed, we performed in situ hybridization on early C. remanei embryos using an antisense Cr-med-3 probe. As the Cr-med genes share several regions of as high as 90% sequence identity (data not shown), this probe is capable of detecting all seven putative Cr-med genes simultaneously. We observed strong signal in the C. remanei EMS Fig. 3 . Alignment of all known MED proteins. White text on a black background indicates identities with Cr-MED-1, while black text on a gray background indicates a conservative change as defined by the BLOSUM62mt2 matrix (Henikoff and Henikoff, 1992) . Amino acid positions relative to the start codon are indicated. For Cr-MED-2, an additional 14 codons specified upstream of the putative start codon have been included in the alignment. Asterisks indicate residues that are conserved in all MED coding regions (excepting those in Cr-MED-2 that occur upstream of its putative start codon).
blastomere (Fig. 6D) . We did not detect expression in other embryonic stages (not shown). In parallel experiments with Cbmed-1, we observed expression in EMS in C. briggsae embryos (data not shown). Therefore, at least one med gene is transcribed in EMS in C. remanei and C. briggsae. To evaluate whether multiple C. remanei med genes are expressed, we performed RT-PCR on early embryo RNA. We found evidence that at least five of the Cr-med genes (Cr-med-1, -3, -5, -6, and -7) are expressed (Fig. 6G) . Taken with the result that we did not see in situ hybridization outside the EMS cell, we conclude that at least five of the C. remanei med genes are expressed in the early embryo.
We next evaluated the ability of a C. remanei med gene reporter to express appropriately when introduced into C. elegans. A C. elegans med-1::GFP::MED-1 fusion (pMM280) expresses in the nucleus of E and MS and their daughters (Figs. 6B -C) (Maduro et al., 2001 ). We constructed a Cr-med-1::GFP::MED-1 construct, pMM808. C. elegans embryos transgenic for pMM808 as an extrachromosomal array (strain MS240) display an expression pattern indistinguishable from the C. elegans reporter (Figs. 6E, F) . With both the C. elegans and C. remanei fusions, no significant expression was observed outside the early E and MS lineages (data not shown). In similar experiments, C. elegans embryos transgenic for a C. briggsae med-1::YFP fusion showed expression in the early MS and E lineages (not shown).
As embryonic activation of Ce-med-1,2 is dependent on activity of skn-1, we tested whether this was true of the Crmed-1 reporter expressed in C. elegans. Such dependence is expected because of the presence of SKN-1 site clusters in the Cr-med-1 promoter. Indeed, while 51% (n = 106) of untreated MS240 embryos at the 8-to 16-cell stage express the Cr-med-1 reporter, expression was not detected in any similarly-staged embryos (n = 122; P < 0.0001) when skn-1 was targeted by RNAi. We conclude that like Ce-med-1, a Cr-med-1 reporter transgene is activated in a SKN-1-dependent manner when introduced into C. elegans.
Chromosomal Ce-med mutants show that the meds are essential genes RNA interference (RNAi) can be used to produce entire broods of phenocopy mutants for many targeted genes (Fire et elegans GATA factors (END-1 and ELT-1; sequences from Wormbase, http://www.wormbase.org), a fungal GATA factor (A. niger AreA; Accession number CAA57524), and chicken GATA1 (Gg-GATA1; Accession number A32993). For the two-fingered proteins ELT-1 and GATA1, only the carboxyl finger (Cf) and basic domain are shown. (B) Relatedness tree generated by AlignX (Vector NTI 6, ClustalW algorithm) from the alignment shown in panel A, showing that the MED proteins form a subgroup diverged from other GATA factors. Note that this particular alignment (which includes only one MED DBD from each species) suggests that the homologs of C. remanei and C. briggsae are more closely related to each other than to C. elegans MED-1, consistent with their apparent evolutionary relationship (Cho et al., 2004; Kiontke et al., 2004) . (C) In an alignment of the DBDs of all MEDs from all three species (rooted using Ce-END-1 and chicken GATA-1 as outgroups, not shown), the Ce-MEDs are found to be more closely related to the Cr-MEDs than the Cb-MEDs, and support is found for a single ancestral MED gene. The horizontal time scales in panels B and C are not identical.
al., 1998). RNAi targeted to Ce-med-1,2 produces a small number of arrested embryos that show defects in MS and E specification, along with many viable animals (Maduro et al., 2001) . As the only means used to assess med-1,2 function was RNAi, an absolute requirement for med-1,2 function was not proven, nor was there a good means of assessing the med function of exogenous transgenes (i.e. by rescue). We constructed a strain, MS247, that generates bona fide med-1,2(À) mutant embryos. MS247 is homozygous for med-1(ok804), a deletion removing the entire Ce-med-1 coding region, and med-2(cx9744), an insertion of a heterologous transposable element that is predicted to abrogate Ce-med-2 function (see Fig. 8 ) (Granger et al., 2004) . The strain is balanced by a large free duplication, irDp1, that provides med function and expresses an unc-119::YFP marker that enables identification of animals that have inherited it. All med-1(ok804); med-2(cx9744) embryos made by MS247 undergo embryonic arrest. These embryos lack posterior pharynx, which is made by MS, and a further 42% also lack endoderm (Figs. 7A -D) . In isolation, >95% of single med-1(ok804) or med-2(cx9744) mutant embryos are completely viable. Hence, the med genes together are indeed essential for embryogenesis as originally proposed (Maduro et al., 2001) , and the small number of mutants that result from med-1,2(RNAi) results from poor RNAi effectiveness with these genes.
We attempted to obtain Cr-med(RNAi) embryos by injecting high concentrations of Cr-med-1 or Cr-med-3 dsRNA directly into female gonad arms, which is expected to produce the strongest possible RNAi effects (Fire et al., 1998; Maduro et al., 2001; Montgomery, 2004) . While several med-like progeny (many of which appeared to also lack endoderm) were observed, similar embryos were also found after injection of control GFP dsRNA and even in untreated animals (data not shown). The high background of arrested embryos (5-20%) in our C. remanei strain, coupled with the apparent low efficacy of RNAi targeted to the Cr-meds (as occurs in C. elegans), leaves us unable to correlate a specific phenotype with loss of Cr-med function.
Most of the Cr-med and Cb-med genes can substitute for Ce-med-1,2
As another approach to evaluate the functional conservation of the Cr-med genes, we tested the ability of the Cr-meds to complement the C. elegans med-1,2(À) mutant strain. We coinjected the Cr-med-1::GFP::MED-1 plasmid with the rol-6 D transformation marker (Mello et al., 1991) into MS247. Among the progeny were Rol animals that had lost both expression of the irDp1-associated unc-119::YFP marker, as well as an adult egg-laying defect associated with irDp1, suggesting that the rescuing function of irDp1 was now being provided by an array containing Cr-med-1(+). Two lines were obtained that appeared to have lost irDp1, and which produced broods consisting of arrested Med embryos and viable embryos (Figs. 7E -F) that developed into fertile adults. Using PCR, we tested genomic DNA of one line (MS268) and confirmed that irDp1 was no longer present (Fig. 8) . This confirms that the Cr-med-1::GFP::MED-1 transgene is able to rescue med-1(ok804); med-2(cx9744) embryos to complete viability. We next tested each of the med homologs for their ability to complement the lethality of C. elegans med-1(ok804); med-2(cx9744) embryos. For each homolog, plasmids or PCR products containing each gene were coinjected with an unc-119::CFP reporter into MS247. We note that as extrachromosomal arrays typically consist of many copies of the injected DNA (Mello et al., 1991) , this type of rescue assay is at best semi-quantitative in nature. For all med homologs except Crmed-2 and Cr-med-7, we obtained lines that had lost the parent irDp1 balancer and were now completely dependent upon the transgene.
Using the cotransformed unc-119::CFP marker, which can be detected at all stages after midembryogenesis, we quantified the degree of rescue by scoring the proportion of array-carrying animals that were restored to embryonic viability (Table 1) . We found that while 97-98% of embryos carrying Ce-med-1(+) or Ce-med-2(+) were rescued, the proportion of fully-rescued animals carrying an interspecific med transgene was generally lower. For all homologs except Cr-med-2 and -7, a significant fraction of transgenic embryos (between 7 and 67%) was inviable. By Nomarski optics, many of these embryos elongated beyond two-fold, but had apparent defects in the morphology of the posterior pharynx, with some having only a slightly irregular grinder (data not shown), suggesting that a failure to completely specify MS (rather than E) accounts for the lack of complete rescue. Indeed, endoderm was made by a higher proportion of these arrested embryos (between 85% and 100%) than by arrested nontransgenic embryos (58%; P < 0.01 for all except Cr-med-6, which has a P = 0.07), consistent with a greater ability of the med homologs to rescue the partial E defect of med-1,2(À) embryos.
While the aforementioned med homologs rescued the vast majority of transgenic embryos, Cb-med-2, Cr-med-2, and Crmed-7 showed marked differences in their abilities to complement a C. elegans med-1,2(À) strain. First, while we were able to obtain a single rescuing line for Cb-med-2, the majority of transgenic embryos (67%) were inviable. This may be due only to the line itself, as one line (MS317) for Cr-med-4 also showed 32% viability, while the other Cr-med-4 line (MS393) showed 97% (the data in the table are pooled). Hence, we can make no strong conclusion about Cb-med-2 function other than it is capable of rescue. Second, the genes Cr-med-2 and Cr-med-7 were unable to rescue to viability. Among arrested embryos, 61% (57/94) of med-1,2(À); Ex[Cr-med-2] embryos made endoderm, which is comparable to the 58% that did so in nontransgenic med-1,2(À) embryos (P = 0.7). In contrast, 90% (53/59) of med-1,2(À); Ex[Cr-med-7] embryos Fig. 7 . The function of the MEDs is conserved between C. elegans and C. remanei. (A-D) C. elegans med-1(ok804); med-2(cx9744) mutant embryos, which fail to elongate beyond 2-fold and lack posterior pharynx as seen by Nomarski optics (A, C). 58% (n = 120) of med-1,2(À) mutants make endoderm (arrowheads in panel B), while the remaining 42% do not (D) as assayed by the presence of gut granules under polarized light. (E -F) C. elegans med-1,2(À) embryo rescued by a Cr-med-1::GFP::MED-1 transgene array. The animal has undergone complete elongation, posterior pharynx is present as evidenced by the prominent grinder (gr), and endoderm is present (arrowheads in panel J). Fig. 6 . Expression of C. elegans and C. remanei med genes is conserved. Top row: in situ hybridization of a 4-cell C. elegans embryo with a Ce-med-1 probe reveals transcription in the nucleus of EMS (A). A C. elegans med-1::GFP::MED-1 translational fusion shows nuclear signal in the EMS daughters MS and E (B), and in their daughters (C). Bottom row: in situ hybridization of a C. remanei embryo with a Cr-med-3 probe reveals transcription in the EMS nucleus (D). The nucleotide sequence similarity among the C. remanei med paralogs predicts that this probe will detect all med mRNAs simultaneously. A translational Cr-med-1::GFP::MED-1 fusion, introduced into C. elegans, displays a similar pattern of activation in E and MS (E) and their daughters (F). (G) Gene-specific RT-PCR products from early C. remanei embryos, showing detection of transcripts from five Cr-med genes (lanes marked F+_). Lanes corresponding to control reactions lacking reverse transcriptase are shown as FÀ_. Amplification was not observed for Cr-med-2 and Cr-med-4 (not shown).
made endoderm (P < 0.0001). Hence, both Cr-med-2 and Crmed-7 fail to rescue the MS specification defect, but where Crmed-2 also fails to rescue E specification, there is evidence that Cr-med-7 can rescue E fate. Perhaps not surprisingly, these two genes are the very ones whose promoters differ from the other (rescuing) genes in that they lack clusters of overlapping SKN-1 sites as discussed earlier. The presence of a conserved, intact open reading frame in Cr-med-7, and its ability to complement the endoderm defect, suggest that when introduced into C. elegans, the Cr-MED-7 gene product is made from this gene (perhaps at a low level) and that it has at least partial function. In the case of Cr-med-2, the apparent amino truncation of the Cr-MED-2 coding region, and its inability to rescue either the MS or E defects in C. elegans, suggest that the transgene may either not be expressed, or that the short Cr-MED-2 gene product lacks an essential component of MED function.
Taken together with the expression data, we conclude that gene activation and function of the med genes have been conserved among C. elegans, C. briggsae, and C. remanei.
Discussion
In this study, we have shown that: (1) the C. remanei genome encodes seven structural homologs of C. elegans med-1; (2) the collective MED homologs predict functionally important amino acids in the MED zinc finger and basic domain; (3) expression of the C. remanei and C. elegans med genes occurs in the EMS nucleus; (4) a Cr-med-1 translational GFP fusion introduced into C. elegans confers med function and similar expression as a C. elegans reporter; (5) five of the seven C. remanei homologs can complement the embryonic lethality associated with C. elegans embryos lacking med-1,2 function; (6) expression and function of the C. briggsae med genes are similarly conserved. These results provide strong evidence that specification of mesendoderm in these species occurs by similar mechanisms.
Gene duplications among med genes are common
Comparison of the MED amino acid sequences suggests that all intraspecific paralogs arose from a single ancestral gene. The occurrence of seven highly similar Cr-med genes seems, therefore, to represent an extreme case of redundancy arising from gene duplication. In C. elegans and C. briggsae, the med genes exist in only two copies. Many of the non-MED GATA factors are also found in two to three paralogous copies . Ce-end-1 and Ce-end-3 are linked paralogs that function together to specify endoderm (E) fate Maduro et al., 2005a) . In C. briggsae, there is a single Cb-end-1 homolog and two Cb-end-3 homologs (Maduro et al., 2005a) . Within C. elegans, other paralogous pairs are known: Ce-elt-2 and Ce-elt-7 and Ce-egl-18 and Ce-elt-6 (Koh and Rothman, 2001) . Our preliminary examination of the C. remanei genome sequence suggests that with the exception of the meds, a possible duplicate of elt-1, and the absence of the small elt-4 gene, the remaining six C. elegans GATA factors (Ce-elt-2, Ce-elt-3, Ce-egl-18, Ce-elt-6, Ce-end-1, and Fig. 8 . A C. elegans med-1,2(À) strain rescued by Cr-med-1(+) carries no intact Ce-med gene. The ok804 allele of med-1 deletes 2.5 kbp of genomic DNA, including the entire coding region and promoter of med-1, and contains a heterologous insertion of 0.8 kbp. The agarose gel shows results of PCR amplification of C. elegans med-1 and med-2 wild-type and mutant alleles from MS247, a strain rescued by irDp1, and MS268, a strain in which irDp1 has been replaced by an extrachromosomal array containing Cr-med-1(+). To the right of the gel, diagrams (approximately to scale) show the arrangement of PCR primers (arrows) relative to the C. elegans med-1 and med-2 genes. The gray rectangles directly beneath the DNA show the med-1 or med-2 coding regions. For med-1(ok804), the heterologous insertion is shown by a thicker black line between the deletion breakpoints. For med-2(cx9744), the heterologous Mos1 insertion (Granger et al., 2004) is shown as a large gray rectangle.
Ce-end-3) are each represented by a single homolog in C. remanei (data not shown).
Why might so many copies of C. remanei med genes have been maintained through evolution? One hypothesis is that these genes are in the process of acquiring new, essential functions that have caused the duplicated copies to be retained. However, the high degree of sequence relatedness, both within and outside the coding regions, suggests that most of the Crmed genes share similar expression and function, as they are clearly recent duplicates. That the Cr-med genes have retained similar activity is substantiated by the ability of most to complement a C. elegans strain lacking endogenous med function. We did not detect med expression in postgastrulation C. remanei embryos, nor in similar C. elegans embryos expressing a Cr-med-1 reporter, suggesting that the Cr-meds function only in MS and E specification. However, we cannot rule out additional functions of the Cr-MED proteins or postembryonic expression.
An alternative explanation is that the med genes have been maintained by a mechanism that selects for their additive contribution to a single function. If a threshold level of Med activity is critical for robust MS and E specification, gene duplication might have arisen as a means of compensating for decreased activation of individual med genes. If the mechanism that activates the meds became compromised in an ancestral species (e.g. from a reduction in number of SKN-1 sites in a single ancestral med gene), this might create a strong selection for additional Med activity arising from gene amplification. At least in C. elegans, the limiting step in med activation is not SKN-1 activity: in situ hybridization of embryos carrying a multicopy Ce-med-1 transgene displays manyfold higher accumulation of med mRNA than wild-types (not shown), suggesting that expression of med genes is proportional to gene dosage. Hence, gene amplification may simply be a route to increase med expression, and assure that high amounts of MED activity, with the correct kinetics, are produced rapidly during a critical developmental time point.
Is Cr-med-2 a pseudogene?
The failure of Cr-med-2 to complement a C. elegans med-1,2(À) double mutant, and the absence of a significant number of SKN-1 sites in its putative promoter, suggest that Cr-med-2 may be a pseudogene. A similar situation exists with the C. elegans GATA factor gene elt-2: A 5V truncated coding region, called elt-4, is found several kb upstream of its apparent fullsize paralog, elt-2 (Fukushige et al., 2003) . ELT-2 is essential for the formation of the intestine and is known to function as a transcriptional activator (Fukushige et al., 1998 (Fukushige et al., , 2003 . In contrast, while expression of elt-4 has been demonstrated, there appears to be no phenotypic consequence to its deletion, nor can any biochemical function be assigned to the ELT-4 protein either in vitro or when expressed in yeast (Fukushige et al., 2003) . There is precedent, therefore, for duplication and retention of a fragment of GATA family gene despite any detectable function. As none of our assays directly addressed function or expression of only Cr-med-2 in C. remanei, a role for Cr-MED-2 distinct from early mesendoderm specification cannot be ruled out.
Differential requirements for the MEDs in MS and E fates
Our studies have shown that while the MED genes function in the specification of MS and E, there are different requirements for the MEDs in each of these sister cells. All embryos fail to specify MS in C. elegans med-1,2(À), while only 42% fail to make endoderm. Clearly, the MEDs are critical for MS but dispensable much of the time for E fate. Indeed, we have shown that there are at least three other inputs into E specification: the Wnt effector POP-1, the Caudal-like homeodomain protein PAL-1, and maternal SKN-1 itself Maduro et al., 2005b) .
The critical requirement for MED function in MS rather than E is also apparent in the rescuing abilities of the various med homologs. With the exception of Cr-med-2, rescue of E occurred in more transgenic animals than did complete rescue of MS. As there are other inputs into endoderm specification, this is perhaps to be expected. Recent work has shown that the MED target genes in MS and E are largely nonoverlapping (that is, they function in MS or E but not both) (BroitmanMaduro et al., 2005) . The ability of most of the med homologs to rescue the lethality of a C. elegans med-1,2(À) strain to viability implies that the entire suite of MED target genes can be activated by the Cb-MED and Cr-MED regulators (except Cr-MED-2/7). The reduced ability of these interspecific med homologs to fully rescue the MS defect suggests that there are at least some MS target genes that are exquisitely sensitive to stochastic differences in the levels or function of the transgenic MED proteins. Whether this arises from changes in recognition of cis-regulatory sites by the MEDs, or other aspects of MED expression and function, remains to be elucidated.
Why are all 11 med genes intronless?
In addition to the amino acid similarity and functional conservation, the med genes share one other characteristic, that of intronless coding regions. For the purposes of function, the presence of introns does not appear to be detrimental: both a Cr-med-1::GFP::MED-1 fusion and a Ce-med-1:GFP::MED-1 fusion can each rescue Ce-med-1,2(À) embryos, despite the presence of three introns in the GFP coding region (A. Fire, personal communication) , and the fact that the inserted sequences result in a transgene mRNA that is approximately twice as long as the endogenous med transcripts. However, an effect operating at the level of a single gene in a chromosomal context, as opposed to a multicopy array, cannot be ruled out.
The meds appear to be unusual in their intronless gene structure, as such genes are comparatively rare in C. elegans. Among GATA factors in C. elegans, they are the only intronless ones. A recent study has determined that while 13% of annotated human genes and approximately 18% of Drosophila genes are intronless, only 3% of C. elegans genes lack introns (Sakharkar and Kangueane, 2004; Sakharkar et al., 2005) . Some gene families, such as G-protein coupled receptors (GPCRs) are encoded by primarily intronless genes, perhaps because many copies have arisen by retroposition (Gentles and Karlin, 1999; Roy and Gilbert, 2005) ; however, C. elegans appears to be the exception in this instance, as the majority of its GPCR genes do possess introns (Gentles and Karlin, 1999) . The presence of conserved SKN-1 sites outside the med coding regions suggests that, with the exception of Crmed-2, the meds have undergone amplification by a process that duplicates both the transcribed and flanking sequences, rather than a mechanism that requires an mRNA intermediate. Alternatively, a mechanism may exist that strongly selects against acquisition of introns in med genes. For example, gene conversion events among the meds could account for both the lack of introns and the apparent coevolution of med sequences within each species. Identification of more med homologs from other species, or demonstration of a gene conversion mechanism in C. elegans, may help resolve this question.
A conserved early mesendoderm network
The foregoing studies provide strong evidence that despite the divergence among the C. elegans and C. remanei med genes, they are activated in the same spatiotemporal pattern (i.e. immediately downstream of SKN-1), and most of these genes have retained the ability to activate the same sets of target genes as determined by inter-species rescue. Hence, while the med gene family has undergone much duplication in C. remanei, most of the paralogs still function in the context of a similar gene regulatory network that specifies the MS and E fates (Fig. 1) . This suggests that despite tens of millions of years of evolution, the mechanism that specifies early mesendoderm fates in Caenorhabditis involves deployment of the same sets of genes. This is perhaps not that surprising, as more distant nematodes, such as Halicephalobus (Panagrolaimidae) and Rhabditophanes (Rhabditidae), show very similar early development as C. elegans in the establishment and position of the early founder cells, including MS and E (Borgonie et al., 2000) . It will therefore be of interest to identify more med homologs from more distant species, and begin a directed approach to structure -function analysis of the MED class of zinc finger proteins.
Note added in proof
We have recently been made aware of two additional candidate C. briggsae med-like genes: Wormbase CDG00186 (an apparent pseudogene) and CDG15489.
